It is important to note that FBXL2 has been previously implicated in cancer, but rather acting via the suppression of cell cycle progression and proliferation, as observed in lung tumors 43, leukemic cells 44, gastric cancer cells 45, and prevalently of tumor suppressive nature. Here, FBXL2 is linked to neoplasm.